Events | Nanotechnology: CSR Implications and Stakeholder Expectations
Date & Time
May 16, 2011
2-5 p.m.
Location
AstraZeneca, 2 Kingdom St, London W2 6BD, United Kingdom; Room: Indian, Level 7
Cost
Free for BSR members
Registration
RSVP: To Karine Cariou by Wednesday, May 11, 2011
Join BSR for a panel discussion on nanotechnology and how it could affect the pharmaceutical, consumer goods, and food, agriculture, and beverage industries. The discussion will include an introduction to this new technology, an overview of some of the ethical, environmental, and social implications, and insights from a recently conducted pilot project with stakeholders on their expectations for the development and use of nanotechnology.
Who Should Attend?
This session is open to BSR members in the pharmaceutical, health care, consumer products, and food, agriculture, and beverage sectors. CSR professionals as well as product development managers, risk managers, and marketing and legal professionals will get the most out of this event.
For more information on the event, please download the agenda.
Speakers
- Dr. David Hollinshead, Director Science Policy, AstraZeneca
- Mike King, MATTER
-
2011
-
2011
-
2011
-
2011
-
2011
- Jan
- Feb
- Mar
- Apr
- May
- Jun
- Jul
- Aug
- Sep
- Oct
- Nov
- Dec
French-language Events
See our French-language events →
